Bio-Rad Laboratories (BIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 530,644 | 536,832 | 509,344 | 602,635 | 505,066 |
| Cost of Goods | 242,068 | 239,590 | 234,055 | 279,886 | 220,850 |
| Gross Profit | 288,576 | 297,242 | 275,289 | 322,749 | 284,216 |
| Operating Expenses | 255,404 | 252,145 | 254,873 | 271,318 | 256,008 |
| Operating Income | 33,240 | 45,687 | 20,471 | 52,317 | 29,058 |
| Interest Expense | 7,710 | 5,564 | 3,857 | 7,019 | 31,611 |
| Other Income | -3,054 | 8,674 | -2,076 | -788 | -2,663 |
| Pre-tax Income | 22,476 | 48,797 | 14,538 | 44,510 | -5,216 |
| Income Tax | 10,967 | 17,166 | 7,870 | 14,374 | 1,883 |
| Net Income Continuous | 11,509 | 31,631 | 6,668 | 30,136 | -7,099 |
| Net Income | $11,509 | $31,631 | $6,668 | $30,136 | $-7,099 |
| EPS Basic Total Ops | 0.40 | 1.10 | 0.23 | 1.05 | -0.25 |
| EPS Basic Continuous Ops | 0.40 | 1.10 | 0.23 | 1.05 | -0.25 |
| EPS Diluted Total Ops | 0.39 | 1.09 | 0.23 | 1.04 | -0.25 |
| EPS Diluted Continuous Ops | 0.39 | 1.09 | 0.23 | 1.04 | -0.25 |
| EBITDA(a) | $33,240 | $45,687 | $20,471 | $52,317 | $29,058 |